These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10186960)

  • 1. The effect of flow rate on drug delivery from the Pulvinal, a high-resistance dry powder inhaler.
    Meakin BJ; Ganderton D; Panza I; Ventura P
    J Aerosol Med; 1998; 11(3):143-52. PubMed ID: 10186960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products.
    Ross DL; Schultz RK
    J Aerosol Med; 1996; 9(2):215-26. PubMed ID: 10163351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do all dry powder inhalers show the same pharmaceutical performance?
    Taylor A; Gustafsson P
    Int J Clin Pract Suppl; 2005 Dec; (149):7-12. PubMed ID: 16279997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler.
    Chew NY; Chan HK
    J Aerosol Med; 2001; 14(4):495-501. PubMed ID: 11791690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler.
    Tarsin W; Assi KH; Chrystyn H
    J Aerosol Med; 2004; 17(1):25-32. PubMed ID: 15120010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
    Munzel U; Marschall K; Fyrnys B; Wedel M
    Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting an accessory device with a metered-dose inhaler: variable influence of accessory devices on fine particle dose, throat deposition, and drug delivery with asynchronous actuation from a metered-dose inhaler.
    Wilkes W; Fink J; Dhand R
    J Aerosol Med; 2001; 14(3):351-60. PubMed ID: 11693847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates.
    Chrystyn H
    Respir Med; 2003 Feb; 97(2):181-7. PubMed ID: 12587970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers.
    Weers J; Clark A
    Pharm Res; 2017 Mar; 34(3):507-528. PubMed ID: 27738953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained mechanical and clinical functionality of the flexhaler dry powder inhaler.
    Lööf T; Elfman P; Ström P; Törngren A; Borgström L
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):381-8. PubMed ID: 18823260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers.
    Smith KJ; Chan HK; Brown KF
    J Aerosol Med; 1998; 11(4):231-45. PubMed ID: 10346666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 2: Air inlet size.
    Coates MS; Chan HK; Fletcher DF; Raper JA
    J Pharm Sci; 2006 Jun; 95(6):1382-92. PubMed ID: 16625656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NanoCluster budesonide formulations enable efficient drug delivery driven by mechanical ventilation.
    Pornputtapitak W; El-Gendy N; Mermis J; O'Brien-Ladner A; Berkland C
    Int J Pharm; 2014 Feb; 462(1-2):19-28. PubMed ID: 24374223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler.
    Chavan V; Dalby R
    AAPS PharmSci; 2002; 4(2):E6. PubMed ID: 12102616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.